SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
America Stem Cell, Inc. (Floresville, TX) Awarded a Phase I STTR to Explore the Therapeutic Potential of Its Platform Technology (ASC-101) With Amniotic Fluid-Derived Stem Cells